beta blockers and glp-1 Advances in GLP-1 receptor agonists delivery systems for obesity and diabetes GLP-1 | Summary

Brain nuclei such as the nucleus of the solitary tract (NST), the arcuate (ARC), the paraventricular region of the hypothalamus (PVH), control meal size of and modulate feelings of satiety

222,223 The protective effects of Klotho extend to the liver, where it contributes to the regulation of glucose and lipid metabolism and protects against liver fibrosis and steatosis

Murphy, K., Travers, P., Walport, M., & Janeway, C

Future Outlook The GLP-1 Drug Market size is projected to reach USD 42.0 billion by 2035, growing at a CAGR of 13.17%, driven by increasing diabetes prevalence, rising obesity rates, and advancements in drug formulations